Chamomile Flower (matricaria Chamomilla L.)

Chamomile flower refers to the dried florets of Matricaria chamomilla L., commonly known as German chamomile or wild chamomile. This botanical ingredient is obtained from the flowering heads of the plant and has been used in traditional medicine and culinary applications for centuries across Europe, Asia, and North America. The material is typically dried and may be used whole, ground, or as an extract in various food and beverage applications.

Chamomile flower is most commonly encountered in herbal tea blends, where it serves as the primary ingredient or a complementary component. Beyond beverages, chamomile has been incorporated into a limited range of food products, including baked goods, confections, and flavoring preparations. In the United States, chamomile products are primarily marketed as dietary supplements or herbal teas rather than conventional food additives. The ingredient is also used in cosmetic and personal care products.

The specific function of chamomile flower as a food additive—whether as a flavoring agent, colorant, or functional ingredient—has not been formally defined within regulatory frameworks. This ambiguity reflects the ingredient's historical use as a whole botanical rather than its application as a processed food additive.

Chamomile flower has generated no adverse event reports in the FDA database and has not been associated with any product recalls. The ingredient has a long history of use in traditional beverages without documented safety incidents at typical consumption levels.

The European Food Safety Authority (EFSA) has evaluated chamomile flower and its extracts. Safety assessments have generally not identified significant toxicological concerns at conventional dietary exposure levels. However, the absence of adverse events does not constitute formal approval or a complete safety evaluation by regulatory agencies.

Certain populations should exercise caution: individuals with allergies to plants in the Asteraceae family (including ragweed, chrysanthemums, and dahlias) may experience cross-reactivity. Additionally, pregnant women and nursing mothers should consult healthcare providers before consuming chamomile products, as safety data in these populations is limited. Some drug interaction potential exists, particularly with sedative medications and anticoagulants, though evidence is inconsistent.

The safety profile of chamomile flower is generally consistent with other traditional herbal ingredients used in food applications, though rigorous modern safety testing specific to food additive use remains limited.

Chamomile flower has not been granted GRAS (Generally Recognized as Safe) status by the FDA, meaning it cannot be directly added to conventional foods without prior approval. In the United States, chamomile products are primarily regulated as dietary supplements under the Dietary Supplement Health and Education Act (DSHEA) or as herbal teas, which fall under different regulatory frameworks than food additives.

In the European Union, chamomile flower is recognized in the Traditional Herbal Registration and appears on food additive lists for certain applications, though specific permitted uses vary by member state. Canada's Natural and Non-prescription Health Products Directorate (NNHPD) permits chamomile in licensed natural health products.

The lack of GRAS status reflects the regulatory requirement that intentional food additives undergo formal safety evaluation and that their specific function in food be clearly defined—neither of which has occurred for chamomile flower as a food additive.

While chamomile flower has been extensively studied for traditional medicinal properties, peer-reviewed research specifically addressing its safety and efficacy as a food additive is limited. Available toxicological data derives primarily from studies of chamomile extracts and essential oils rather than the whole flower ingredient.

Studies examining chamomile's chemical composition have identified compounds including apigenin, bisabolol, and various flavonoids. These constituents have been individually evaluated in some research contexts, but comprehensive safety data for the whole plant ingredient in food applications remains incomplete.

The absence of formal FDA or EFSA additive safety assessments means that definitive conclusions about safe usage levels in food cannot be established from regulatory documentation. Future research would benefit from standardized toxicological testing and human safety studies specific to food additive applications.